A Real-World Study of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder (P11-8.012)
This study aims to evaluate the efficacy and safety of inebilizumab in Chinese patients with aquaporin-4 immunoglobulin G (AQP4-IgG) positive neuromylitis optic spectrum disorders (NMOSD) in a real-world setting.
Authors
- Jing Lin (ORCID: https://orcid.org/0000-0001-5901-0498)
- Mengcui Gui
- Yue Li (ORCID: https://orcid.org/0000-0003-3098-8913)
- Bitao Bu (ORCID: https://orcid.org/0000-0003-3686-4153)
- Jiayang Zhan
Institutions
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210762
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00